Key Takeaways (4-6 bullets, will render as highlighted box)
- The Novo Nordisk Wegovy savings offer can reduce eligible commercially insured patients' copay to as little as $0 to $25 per fill, with maximum monthly benefit caps that change yearly.
- Government-insured patients (Medicare, Medicaid, TRICARE, VA) are excluded from the savings card. This is a federal anti-kickback law restriction, not a Novo Nordisk choice.
- The card only reduces copays. It does not provide coverage. If your plan does not cover Wegovy at all, the savings card cannot help.
- Cash-pay patients (no insurance) cannot use the savings card directly but can sometimes access Novo Nordisk's discounted cash-pay program, currently around $499 per month.
- Patients with no commercial insurance or income below 400% of federal poverty level may qualify for the Novo Nordisk Patient Assistance Program (PAP), which can provide Wegovy free.
Direct answer (40-60 words)
The Wegovy manufacturer coupon, called the Wegovy Savings Offer by Novo Nordisk, can reduce eligible commercially insured patients' monthly copay to as little as $0 to $25 per fill. Patients on Medicare, Medicaid, TRICARE, or any government plan are excluded by federal law. The card has annual benefit caps and a maximum 12 to 24 months of use per patient.
Table of contents
- The 30-second answer
- What the Wegovy savings card is and isn't
- Who qualifies (and who doesn't)
- What it actually saves: real scenarios
- How to get and use the card
- Why government-insured patients can't use it
- The cash-pay program: NovoCare direct pricing
- Patient assistance program for low-income patients
- What to do if you don't qualify for any program
- FAQ
- Sources
- Footer disclaimers
What the Wegovy savings card is and isn't
The Wegovy savings card is a manufacturer copay assistance program from Novo Nordisk. It reduces the out-of-pocket cost for commercially insured patients whose insurance covers Wegovy.
See transparent compounded pricing
Review compounded GLP-1 pricing and what provider-reviewed care includes, with no surprises at checkout.
Try the Cost Calculator →What it is:
- A copay reduction tool for patients with commercial insurance that covers Wegovy
- Active for a defined period (typically 12 to 24 months) per patient
- A way to bring monthly costs down from $200 to $400 copays to as little as $0 to $25 per fill, depending on plan
- Distributed by Novo Nordisk through its NovoCare program
What it isn't:
- Insurance. The card doesn't cover anything. It only reduces what your insurance already lets you owe.
- Useful for the uninsured. If you have no insurance, the card has no copay to reduce.
- Available to government-insured patients. Medicare, Medicaid, TRICARE, and VA patients are excluded by federal law.
- A way around prior authorization. Your insurance still has to approve coverage first.
The most common confusion: patients assume the card is a coupon they can redeem for $499 Wegovy regardless of insurance. It isn't. The card is a benefit layered on top of existing coverage.
Who qualifies (and who doesn't)
Eligible:
- Adults 18+
- U.S. residents
- Have commercial (private, employer, or marketplace) prescription drug coverage that includes Wegovy
- Have a valid prescription for Wegovy from a U.S.-licensed clinician
- Diagnosis aligns with Wegovy's FDA-approved use (BMI 30+ or BMI 27+ with one weight-related comorbidity)
Not eligible:
- Anyone enrolled in Medicare (Part D, Medicare Advantage, or any Medicare drug plan)
- Anyone enrolled in Medicaid or any state-funded health program
- Anyone enrolled in TRICARE, the VA, or another federal program
- Anyone uninsured
- Anyone whose commercial plan does not cover Wegovy at all
- Patients in any state where the program is restricted by state law
The rule about government-insured patients is not a Novo Nordisk preference. The federal anti-kickback statute prohibits manufacturers from offering copay assistance to patients whose drugs are paid for by federal programs. Violators face civil penalties and exclusion from federal healthcare programs (HHS OIG advisory opinions on copay assistance programs).
What it actually saves: real scenarios
The Wegovy savings card has tiered benefits depending on whether your plan covers Wegovy and how much your copay is.
Scenario 1: Commercial plan covers Wegovy with low copay.
- Plan copay: $50 per fill
- Savings card brings copay to: $0 to $25 (depending on current Novo Nordisk benefit)
- Out of pocket: $0 to $25 per month
Scenario 2: Commercial plan covers Wegovy with high copay.
- Plan copay: $400 per fill
- Savings card maximum benefit: capped per fill (typically $200 to $300)
- Out of pocket: roughly $100 to $200 per month after card
Scenario 3: Commercial plan does not cover Wegovy.
- Wegovy is not on formulary
- Savings card cannot help (no copay to reduce)
- Out of pocket: full retail (about $1,400 per month) or pivot to cash-pay program
Scenario 4: High-deductible plan, deductible not met.
- Pre-deductible cost: full negotiated rate (about $1,300 to $1,400)
- Savings card maximum: capped, not enough to bring close to $0
- Out of pocket: still hundreds per fill until deductible is met
Scenario 5: Medicare patient.
- Plan copay: $400 per fill (typical specialty tier)
- Savings card: not allowed
- Out of pocket: $400 per fill, plus coverage gap implications
The pattern: the savings card is best for patients with covered Wegovy and moderate copays. It's of limited help for patients with no coverage, high deductibles unmet, or government insurance.
How to get and use the card
Step 1: Confirm Wegovy is covered by your plan. Call your insurance member services or check your plan's online formulary. Search for "semaglutide 2.4 mg" or "Wegovy." Note the tier and whether prior authorization is required.
Step 2: Get a Wegovy prescription. Through your primary care doctor, an obesity medicine specialist, or a licensed telehealth platform. The prescriber will submit prior authorization if your plan requires it.
Step 3: Download the savings card. Visit the NovoCare website (NovoCare.com/Wegovy) or the dedicated savings card page. You'll fill in basic information (name, ZIP code, insurance status) and receive a digital savings card you can print or save to your phone.
Step 4: Bring both your insurance card and the savings card to the pharmacy. The pharmacist runs your insurance first, calculates your copay, then applies the savings card. Most major pharmacy chains process the savings card directly through their system; some require you to provide the BIN, PCN, group, and member ID printed on the card.
Step 5: Keep records. The savings card has annual benefit limits. After hitting the cap, you'll pay your normal copay until the next year. Some plans reset annually; check your specific card's terms.
If the pharmacist says the card "isn't going through," the most common causes are: government insurance involvement (the card is being correctly rejected), prior authorization not approved, or pharmacy data not yet updated. Call the NovoCare helpline (printed on the card) to troubleshoot.
Why government-insured patients can't use it
This is the most asked question about manufacturer coupons in general.
The legal reason: The federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)) prohibits drug manufacturers from offering anything of value to induce the prescribing or purchase of a drug paid for by a federal health program. The HHS Office of Inspector General has interpreted manufacturer copay coupons as inducements (HHS OIG, multiple advisory opinions).
If a manufacturer offers a coupon to a Medicare patient, both the manufacturer and the patient may be subject to enforcement action. The manufacturer can face civil penalties and exclusion from Medicare; the patient could be required to repay any covered amount.
Practical implication: Pharmacies are required to identify when a patient is on a government plan and reject the coupon at the point of sale. This is a legal requirement, not a customer-service decision.
Workarounds for government-insured patients:
- Apply for the Novo Nordisk Patient Assistance Program (income-based)
- Use Medicare's Extra Help program if low-income
- Enroll in a Medicare Part D plan that covers Wegovy if your current plan doesn't
- For Medicaid patients, check the state's preferred drug list and prior authorization process
- Pivot to compounded semaglutide, which Medicare does not cover but where cash pricing can be lower
The cash-pay program: NovoCare direct pricing
In 2024, Novo Nordisk launched a direct-to-patient cash-pay program for Wegovy through NovoCare. Pricing has shifted; current 2026 pricing is approximately $499 per month for a single all-doses option.
Who it's for:
- Patients with no insurance
- Patients whose insurance does not cover Wegovy at all
- Patients who prefer to skip the prior authorization process
How it works:
- Visit NovoCare.com/wegovy
- Enroll, share prescription information
- Wegovy ships from a Novo Nordisk-partnered pharmacy
- Pay direct to the pharmacy at the discounted price
Limitations:
- Cannot be combined with insurance
- Cannot be combined with the savings card
- Pricing is subject to change (Novo Nordisk has adjusted the cash price more than once since launch)
Comparison:
| Path | Approximate monthly cost |
|---|---|
| Wegovy with strong commercial coverage and savings card | $0 to $25 |
| Wegovy with moderate commercial coverage and savings card | $50 to $200 |
| Wegovy with weak coverage / high deductible | $400 to $1,400 |
| Wegovy with NovoCare cash-pay program | $499 |
| Brand-name Wegovy retail (no insurance, no programs) | $1,300 to $1,500 |
| Compounded semaglutide (FormBlends) | $179 to $279 |
| Patient Assistance Program (income-eligible) | $0 |
For most uninsured patients without diabetes, compounded semaglutide ends up being the most affordable monthly option, though it's not interchangeable with Wegovy.
Patient assistance program for low-income patients
Novo Nordisk's Patient Assistance Program (PAP) provides Wegovy at no cost to patients who meet income criteria.
Eligibility (as of 2026):
- Household income below 400% of the federal poverty level (about $60,240 for individuals, $124,800 for families of four)
- U.S. resident or legal U.S. resident
- No prescription drug coverage (or coverage that does not cover Wegovy)
- Valid prescription from a U.S.-licensed clinician
What it provides:
- Wegovy free for up to 12 months at a time, renewable
- Shipped directly from Novo Nordisk to the patient
- No copay, no deductible, no insurance involvement
How to apply:
- Application form available on the NovoCare website
- Patient completes the financial section
- Provider completes the medical necessity section
- Submit by mail or fax through the prescribing office
- Approval typically takes 5 to 10 business days
The PAP is consistently underutilized. Many patients qualify but don't apply because they don't know it exists. If your monthly Wegovy cost is unsustainable and you're under the income threshold, ask your provider to start a PAP application.
What to do if you don't qualify for any program
If you're not eligible for the savings card (government insurance), not eligible for the PAP (income too high), and don't have commercial coverage, the realistic options are:
- Switch insurance during open enrollment. A commercial plan that covers Wegovy may be available through your employer or the marketplace.
- Push for coverage on your current plan. Many plans add or expand GLP-1 coverage year by year. A formal exception request, with documentation of medical necessity, is sometimes granted.
- Pivot to compounded semaglutide. Compounded semaglutide is not interchangeable with Wegovy but uses the same active molecule. Pricing through licensed telehealth platforms typically runs $179 to $279 per month with no insurance involvement.
- Pay cash for Wegovy through NovoCare ($499 per month at current pricing).
- Switch to a different GLP-1. Some plans cover Saxenda or Zepbound but not Wegovy. Discuss with your prescriber.
The right path depends on what you can sustain financially long-term. GLP-1 weight loss is most effective when treatment continues for years, not months, so monthly cost matters more than total annual savings.
Internal links
- For background on Wegovy versus other GLP-1s, see /articles/general-glp1/wegovy-vs-zepbound/
- For overall GLP-1 cost strategies, see /articles/cost-and-insurance/glp1-cost-strategies/
- For details on compounded semaglutide, see /articles/glp1-hub/compounded-semaglutide-for-weight-loss-complete-guide-2026
FAQ
How much does the Wegovy manufacturer coupon save? For commercially insured patients whose plan covers Wegovy, the savings card can reduce monthly copays to as little as $0 to $25, with maximum benefit caps per fill. Real savings depend on your plan's copay structure. Patients with high copays may still pay $100 to $200 monthly after the card.
Can I use the Wegovy savings card with Medicare? No. Federal law prohibits manufacturer copay coupons from being used with Medicare, Medicaid, TRICARE, VA, or any government health program. This is the federal Anti-Kickback Statute. Pharmacies must reject the card when government insurance is involved.
What if my insurance doesn't cover Wegovy? The savings card can't help if your plan doesn't cover Wegovy at all. The card reduces a copay; it doesn't create coverage. Options include: requesting a formulary exception, switching to a covered GLP-1, paying cash through the NovoCare program ($499/month), applying for the patient assistance program, or pivoting to compounded semaglutide.
Where do I get the Wegovy savings card? Through NovoCare.com/Wegovy or the dedicated savings card page on Novo Nordisk's website. Fill in basic information and receive a digital card. You can print it or save it to your phone. Bring it with your insurance card to the pharmacy.
How long can I use the Wegovy savings card? Most program terms allow 12 to 24 months of use per patient, with annual benefit caps. After hitting the annual cap, you pay your normal copay until the next benefit year. Card terms have changed over time; check the current Novo Nordisk program terms when you enroll.
Is the Wegovy cash-pay program the same as the savings card? No. The cash-pay program (about $499/month) is a separate, direct-to-consumer pricing program for patients without insurance or whose insurance doesn't cover Wegovy. The savings card is a copay reducer for patients with commercial coverage. You cannot combine the two.
Can I use the Wegovy savings card if I'm in a marketplace plan? Yes, marketplace plans (Healthcare.gov, state exchanges) are commercial plans for the purpose of the savings card. The card works the same as with employer or individual commercial coverage, as long as your specific plan covers Wegovy.
Does the Wegovy coupon work at all pharmacies? At most major U.S. retail pharmacy chains (Walmart, CVS, Walgreens, Rite Aid, Costco, Sam's Club). Some independent pharmacies may not have the card processing set up. Mail-order pharmacies typically support the card. If a pharmacy says the card won't process, call the NovoCare helpline.
What's the patient assistance program for Wegovy? The Novo Nordisk Patient Assistance Program (PAP) provides Wegovy at no cost to patients with household income below 400% of the federal poverty level who don't have prescription drug coverage. Apply through your provider via the NovoCare website. Approval takes 5 to 10 business days.
Can I use the savings card and a GoodRx coupon together? No. GoodRx coupons replace insurance pricing, while the manufacturer savings card layers on top of insurance pricing. You have to choose one or the other. Compare the two prices and use whichever is lower at your pharmacy.
Why does the pharmacy say my coupon isn't going through? Most common reasons: government insurance is being detected (correct rejection), prior authorization is not yet approved, the savings card is past its annual benefit cap, or the pharmacy's processing system hasn't updated. Call the NovoCare helpline printed on the card to troubleshoot.
Does the savings card cover prior authorization paperwork? No. Prior authorization is between your prescriber and your insurance company. The savings card only reduces the copay after coverage is approved. If your PA is denied, the card has nothing to apply to.
Sources
- Novo Nordisk. Wegovy savings offer terms. NovoCare. 2026.
- Novo Nordisk. Patient Assistance Program for Wegovy. NovoCare. 2026.
- U.S. Department of Health and Human Services, Office of Inspector General. Advisory opinion on manufacturer copay assistance programs.
- Federal Anti-Kickback Statute. 42 U.S.C. § 1320a-7b(b).
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021;384:989-1002.
- American Diabetes Association. Pharmacologic Approaches to Glycemic Treatment. Diabetes Care. 2024;47(Suppl 1):S158-S178.
- Centers for Medicare and Medicaid Services. Part D drug coverage and prior authorization. 2024.
- Novo Nordisk. Wegovy direct cash-pay program announcement and pricing updates. 2024-2026.
- Federal Poverty Level guidelines. U.S. Department of Health and Human Services. 2026.
Footer disclaimers (all 4 verbatim)
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Wegovy, Ozempic, Saxenda, and NovoCare are registered trademarks of Novo Nordisk A/S. Zepbound is a registered trademark of Eli Lilly and Company. Walmart, CVS, Walgreens, Costco, GoodRx, and TRICARE are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →